Combination of SJ733 with Tafenoquine as a Possible 1 or 2 Dose Radical Cure for P. Vivax Malaria

Grants and Contracts Details

StatusActive
Effective start/end date9/12/239/30/25

Funding

  • Eisai Incorporated: $192,565.00